1 / 1

Supplemental Figure 1

Supplemental Figure 1. c. . MGC-803. 4. 4. 3. 3. miR-185 levels (fold). 40. TUNEL positive cells (%). 2. 2. . 1. 1. 20. 0. 0. . 60. 60. 0. –. CDDP(30 m M). +. +. +. TUNEL positive cells (%). 40. 40. . –. –. –. miR-185 AntagomiR. +. –. –. –.

alaina
Download Presentation

Supplemental Figure 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplemental Figure 1 c  MGC-803 4 4 3 3 miR-185 levels (fold) 40 TUNEL positive cells (%) 2 2  1 1 20 0 0  60 60 0 – CDDP(30 mM) + + + TUNEL positive cells (%) 40 40  – – – miR-185 AntagomiR + – – – AntagomiR control 4 + 20 20 3 miR-185 levels (fold) 0 0 2 – – DOX (2 mM) + + + + + + – – – – – – f 1 + + miR-185 AntagomiR – – – – – – + + AntagomiR control 0 MGC-803 + miR-185 2 _ _  normal + b-gal 40 _ _ Cleaved Caspase-3 cancer TUNEL positive cells (%) 1.5 Actin 20 – Relative miR-185 levels DOX (2 mM) + + + 1 – – – miR-185 AntagomiR 0 + – – – + miR-185 – – – AntagomiR control + – – – + b-gal 0.5 – + + + CDDP (3 mM) 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Patient Number e a d b

More Related